Quantitative Analysis to Guide Orphan Drug DevelopmentLESKO, L. J.Clinical pharmacology and therapeutics. 2012, Vol 92, Num 2, pp 258-261, issn 0009-9236, 4 p.Article

Pharmacokinetic drug interactions with amiodaroneLESKO, L. J.Clinical pharmacokinetics. 1989, Vol 17, Num 2, pp 130-140, issn 0312-5963Article

Paving the critical path : How can clinical pharmacology help achieve the vision?LESKO, L. J.Clinical pharmacology and therapeutics. 2007, Vol 81, Num 2, pp 170-177, issn 0009-9236, 8 p.Article

Protein binding of nifedipineOTTO, J; LESKO, L. J.Journal of pharmacy and pharmacology. 1986, Vol 38, Num 5, pp 399-400, issn 0022-3573Article

Pharmacogenomic-guided drug development: regulatory perspectiveLESKO, L. J; WOODCOCK, J.Pharmacogenomics journal (Print). 2002, Vol 2, Num 1, pp 20-24, issn 1470-269XArticle

Pharmacokinetic interaction between theophylline and chloramphenicol in ratsBUSBY, M; LESKO, L. J.Drug metabolism and disposition. 1987, Vol 15, Num 2, pp 204-206, issn 0090-9556Article

Protein binding of nifedipineOTTO, J; LESKO, L. J.Journal of pharmacy and pharmacology. 1986, Vol 38, Num 5, pp 399-400, issn 0022-3573Article

Pharmacological Mechanism-Based Drug Safety Assessment and PredictionABERNETHY, D. R; WOODCOCK, J; LESKO, L. J et al.Clinical pharmacology and therapeutics. 2011, Vol 89, Num 6, pp 793-797, issn 0009-9236, 5 p.Article

Personalized medicine : Elusive dream or imminent reality?HOFFMANN, D. E; ROSES, A; LESKO, L. J et al.Clinical pharmacology and therapeutics. 2007, Vol 81, Num 6, issn 0009-9236, 799-801, 801-805, 807-816 [18 p.]Article

Physical-chemical compatibility of cromolyn sodium nebulizer solution. Bronchodilator inhalant solution admixturesLESKO, L. J; MILLER, A. K.Annals of allergy. 1984, Vol 53, Num 3, pp 236-238, issn 0003-4738Article

Sumultaneous determination of doxepin and nordoxepin in serum using high-performance liquid chromatographyEMM, T; LESKO, L. J; PERKAL, M. B et al.Journal of chromatography. 1987, Vol 419, pp 445-451, issn 0021-9673Article

Systems Approaches in Risk AssessmentLESKO, L. J; ZHENG, S; SCHMIDT, S et al.Clinical pharmacology and therapeutics. 2013, Vol 93, Num 5, pp 413-424, issn 0009-9236, 12 p.Article

Transporter-Mediated Drug- Drug InteractionsZHANG, L; HUANG, S.-M; LESKO, L. J et al.Clinical pharmacology and therapeutics. 2011, Vol 89, Num 4, pp 481-484, issn 0009-9236, 4 p.Article

Individualization of Drug Therapy: History, Present State, and Opportunities for the FutureLESKO, L. J; SCHMIDT, S.Clinical pharmacology and therapeutics. 2012, Vol 92, Num 4, pp 458-466, issn 0009-9236, 9 p.Article

Therapeutic Protein―Drug Interactions and Implications for Drug DevelopmentHUANG, S.-M; ZHAO, H; LEE, J.-I et al.Clinical pharmacology and therapeutics. 2010, Vol 87, Num 4, pp 497-503, issn 0009-9236, 7 p.Article

Assessment of the quality and quantity of drug-drug interaction studies in recent NDA submissions : Study design and data analysis issuesHUANG, S.-M; LESKO, L. J; WILLIAMS, R. L et al.Journal of clinical pharmacology. 1999, Vol 39, Num 10, pp 1006-1014, issn 0091-2700Article

Development of in vivo bioequivalence methodology for dermatologic corticosteroids based on pharmacodynamic modelingGUR JAI PAL SINGH; ADAMS, W. P; LESKO, L. J et al.Clinical pharmacology and therapeutics. 1999, Vol 66, Num 4, pp 346-357, issn 0009-9236Conference Paper

AAPS/FDA Workshop Report: Bioequivalence of topical dermatological dosage forms: Methods of evaluation of bioequivalenceSHAH, V. P; FLYNN, G. L; MARTY, J.-P et al.Pharmaceutical technology. 1998, Vol 22, Num 3, pp 140-148, issn 0147-8087, 5 p.Article

Accumulation of nifedipine after multiple dosesLESKO, L. J; HUNTER, J. R; BURGESS, R. C et al.Journal of pharmacy and pharmacology. 1986, Vol 38, Num 6, pp 486-488, issn 0022-3573Article

Estimation of protein binding of zimelidine and norzimelidine using cerebrospinal fluid and ultrafiltrationLESKO, L. J; FLIORE, D; LESLIE, J et al.Research communications in psychology, psychiatry and behavior. 1986, Vol 11, Num 2-3, pp 95-111, issn 0362-2428Article

Drug interaction studies : Study design, data analysis, and implications for dosing and labelingHUANG, S.-M; TEMPLE, R; THROCKMORTON, D. C et al.Clinical pharmacology and therapeutics. 2007, Vol 81, Num 2, pp 298-304, issn 0009-9236, 7 p.Article

Workshop III report : scaleup of liquid and semisolid disperse systemsVAN BUSKIRK, G. A; SHAH, V. P; GUY, R. H et al.Pharmaceutical research. 1994, Vol 11, Num 8, pp 1216-1220, issn 0724-8741Article

Evaluation of zimeldine in Alzheimer's disease: cognitive and biochemical measuresCUTLER, N. R; HAXBY, J; MOORE, A. M et al.Archives of neurology (Chicago). 1985, Vol 42, Num 8, pp 744-748, issn 0003-9942Article

Rapid GC method for quantitation of nifedipine in serum using electron capture detectionLESKO, L. J; MILLER, A. K; YEAGER, R. L et al.Journal of chromatographic science. 1983, Vol 21, Num 9, pp 415-419, issn 0021-9665Article

Optimizing the science of drug development: opportunities for better candidate selection and accelerated evaluation in humansLESKO, L. J; ROWLAND, M; PECK, C. C et al.European journal of pharmaceutical sciences. 2000, Vol 10, Num 4, pp iv-xiv, issn 0928-0987Article